The bowel and beyond: the enteric nervous system in neurological disorders
暂无分享,去创建一个
[1] J. Jankovic. Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[2] N. Halfon,et al. What DSM-5 could mean to children with autism and their families. , 2013, JAMA pediatrics.
[3] H. Braak,et al. α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei , 2001, Acta Neuropathologica.
[4] F. Jirik,et al. Endogenous cellular prion protein regulates contractility of the mouse ileum , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[5] A. Chiò,et al. Extensive genetics of ALS , 2012, Neurology.
[6] S. Prusiner. Biology and genetics of prions causing neurodegeneration. , 2013, Annual review of genetics.
[7] D. Reis,et al. Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum , 1981, Brain Research.
[8] J. Atkin,et al. Protein folding alterations in amyotrophic lateral sclerosis , 2016, Brain Research.
[9] H. Laude,et al. Endogenous prion protein conversion is required for prion‐induced neuritic alterations and neuronal death , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] R. Pfeiffer,et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation , 1995, The Lancet.
[11] J. Furness. The Enteric Nervous System , 2016, Advances in Experimental Medicine and Biology.
[12] Robert Goodman,et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study∗ ∗ See accompanying Editorial, in this issue. , 2000, Biological Psychiatry.
[13] Masam Yoshida. [Varicella-zoster virus infection]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.
[14] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[15] E. Tolosa,et al. Alpha-synuclein immunoreactivity patterns in the enteric nervous system , 2015, Neuroscience Letters.
[16] M. Gershon. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract , 2013, Current opinion in endocrinology, diabetes, and obesity.
[17] C. Betancur,et al. Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting , 2011, Brain Research.
[18] M. Levin. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] Jun Sun,et al. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model , 2015, Physiological reports.
[20] M. Neunlist,et al. Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System. , 2015, Journal of Parkinson's disease.
[21] William W. Agace,et al. Regional specialization within the intestinal immune system , 2014, Nature Reviews Immunology.
[22] Hyun-Jung Cho,et al. The enteric nervous system and gastrointestinal innervation: integrated local and central control. , 2014, Advances in experimental medicine and biology.
[23] W. Poewe,et al. Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model , 2010, Movement disorders : official journal of the Movement Disorder Society.
[24] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[25] E. Gross,et al. BASIC AND TRANSLATIONAL — ALIMENTARY TRACT Neuronal Serotonin Regulates Growth of the Intestinal Mucosa in Mice , 2012 .
[26] S. Mazmanian,et al. Review Control of Brain Development, Function, and Behavior by the Microbiome Figure 2. Microbiome Influence on Bbb Integrity , 2022 .
[27] J. Trojanowski,et al. Expression patterns of β‐amyloid precursor protein (β‐APP) in neural and nonneural human tissues from alzheimer's disease and control subjects , 1991 .
[28] S. McKeown,et al. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. , 2016, Gene.
[29] C. Carroll,et al. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease , 2014, Acta Neuropathologica.
[30] G. Giannaccini,et al. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. , 2015, Central nervous system agents in medicinal chemistry.
[31] M. Kiaei,et al. Premature death of TDP‐43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis , 2013, International journal of experimental pathology.
[32] Scott F. Hall,et al. Enteric Dopaminergic Neurons: Definition, Developmental Lineage, and Effects of Extrinsic Denervation , 2003, The Journal of Neuroscience.
[33] Kenny Q. Ye,et al. De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.
[34] Jay Shendure,et al. Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development , 2014, Cell.
[35] H. Braak,et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.
[36] Ling-Zhi Wang,et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer , 2013, EMBO molecular medicine.
[37] C. C. Johnson,et al. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.
[38] P. Tam,et al. An immunohistochemical study of neuronal microtubule-associated proteins in Hirschsprung's disease. , 1993, Human Pathology.
[39] J. Tapia,et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function , 2016, Nature Communications.
[40] H. Reichmann,et al. Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors , 2015, Nature Reviews Neurology.
[41] J. Bienenstock,et al. Vagal pathways for microbiome-brain-gut axis communication. , 2014, Advances in experimental medicine and biology.
[42] R. Heuckeroth,et al. Building a second brain in the bowel. , 2015, The Journal of clinical investigation.
[43] T. Powley,et al. Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat , 2009, Experimental Neurology.
[44] B. McConkey,et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.
[45] S. Hamilton-Dutoit,et al. Pathological α‐synuclein in gastrointestinal tissues from prodromal Parkinson disease patients , 2016, Annals of neurology.
[46] M. Gershon,et al. Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice , 2006, The Journal of Neuroscience.
[47] K. Tredici,et al. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases , 2011, Journal of the Neurological Sciences.
[48] M. Neunlist,et al. The digestive neuronal–glial–epithelial unit: a new actor in gut health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.
[49] T. Powley,et al. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease? , 2008, Neuroscience.
[50] C. Duncan,et al. Varicella zoster virus immunity: A primer. , 2015, The Journal of infection.
[51] S. Holland-Cunz,et al. Acquired intestinal aganglionosis after a lytic infection with varicella-zoster virus. , 2006, Journal of pediatric surgery.
[52] J. W. Aldren Turner,et al. THE AUTONOMIC NERVOUS SYSTEM , 1955 .
[53] W. Robberecht,et al. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice , 2014, Molecular Neurodegeneration.
[54] L. Parkkinen,et al. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease , 2015, Neurology.
[55] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[56] J. Neu,et al. Tight junctions, leaky intestines, and pediatric diseases , 2005, Acta paediatrica.
[57] P. Tam. Hirschsprung's disease: A bridge for science and surgery. , 2016, Journal of pediatric surgery.
[58] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[59] M. Phipps,et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.
[60] J. Sweatt,et al. Pitt–Hopkins Mouse Model has Altered Particular Gastrointestinal Transits In Vivo , 2015, Autism research : official journal of the International Society for Autism Research.
[61] Giovanni Di Guardo,et al. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine , 2008, Autonomic Neuroscience.
[62] Subrata Ghosh. Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease. , 2004, Advanced drug delivery reviews.
[63] Hitoshi Takahashi,et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses , 2004, Acta Neuropathologica.
[64] C. Adler,et al. Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss , 2012, Acta Neuropathologica.
[65] P. D'eufemia,et al. Abnormal intestinal permeability in children with autism , 1996, Acta paediatrica.
[66] F. Fornai,et al. Parallel manifestations of neuropathologies in the enteric and central nervous systems , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[67] E. Horváth-Puhó,et al. Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.
[68] Jerrold R. Turner,et al. Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.
[69] W. Shankle,et al. Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: enteric neurons in Alzheimer disease. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[70] N. Weiner,et al. Regulation of norepinephrine biosynthesis. , 1970, Annual review of pharmacology.
[71] J. Furness,et al. Anatomical evidence for ileal Peyer’s patches innervation by enteric nervous system: a potential route for prion neuroinvasion? , 2008, Cell and Tissue Research.
[72] J. Eikenboom,et al. Heparin-Induced Thrombocytopenia. , 2015, The New England journal of medicine.
[73] C. Masters,et al. Transmissible spongiform encephalopathies , 2004, The Lancet.
[74] H. Braak,et al. Pathoanatomy of Parkinson’s disease , 2000, Journal of Neurology.
[75] C. Bern. Chagas' Disease. , 2015, The New England journal of medicine.
[76] K. Jellinger. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. , 2009, Biochimica et biophysica acta.
[77] Mustafa M. Husain,et al. Vagus nerve stimulation: a new tool for brain research and therapy∗ , 2000, Biological Psychiatry.
[78] R. Giorgio. The Enteric Nervous System, J.B. Furness. Blackwell Publishing, Oxford (2006), (274 pp., Price GBP 55.00, ISBN 1-4051-3376-7) , 2006 .
[79] John Q. Trojanowski,et al. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases , 2009, Journal of Neurology.
[80] Jeremy Veenstra-VanderWeele,et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior , 2012, Proceedings of the National Academy of Sciences.
[81] J. Sweatt,et al. Pitt–Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription , 2013, Experimental & Molecular Medicine.
[82] Mogens Vestergaard,et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. , 2013, JAMA.
[83] H. Reichmann,et al. Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice , 2009 .
[84] Udo Rüb,et al. Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.
[85] S. Gruber,et al. Ogilvie syndrome and herpes zoster: case report and review of the literature. , 2010, The Journal of emergency medicine.
[86] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[87] K. Sharkey,et al. Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study , 2008, Journal of autism and developmental disorders.
[88] J. Jankovic,et al. The role of FUS gene variants in neurodegenerative diseases , 2014, Nature Reviews Neurology.
[89] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[90] A. Posar,et al. Autism according to diagnostic and statistical manual of mental disorders 5th edition: The need for further improvements , 2015, Journal of pediatric neurosciences.
[91] J. Langston,et al. Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits , 2012, Neurobiology of Disease.
[92] N. Foster,et al. Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system. , 2015, Journal of Alzheimer's disease : JAD.
[93] K. Tieu,et al. A guide to neurotoxic animal models of Parkinson's disease. , 2011, Cold Spring Harbor perspectives in medicine.
[94] J. Trojanowski,et al. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. , 1991, Annals of neurology.
[95] N. Cairns,et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration , 2009, Proceedings of the National Academy of Sciences.
[96] K. Shannon,et al. Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[97] R. Knight,et al. Gut Microbes and the Brain: Paradigm Shift in Neuroscience , 2014, The Journal of Neuroscience.
[98] L. Davis,et al. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. , 2012, Transactions of the American Clinical and Climatological Association.
[99] M. Sens,et al. Amyloid Precursor Protein Expression Modulates Intestine Immune Phenotype , 2011, Journal of Neuroimmune Pharmacology.
[100] S. B. des Varannes,et al. Routine colonic biopsies as a new tool to study the enteric nervous system in living patients , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[101] A. Aguzzi. Unraveling prion strains with cell biology and organic chemistry , 2008, Proceedings of the National Academy of Sciences.
[102] D. Munoz,et al. Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[103] R. Blakely,et al. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. , 2016, The Journal of clinical investigation.
[104] T. Wyss-Coray,et al. Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression. , 2013, Journal of Alzheimer's disease : JAD.
[105] H. Clevers. The Intestinal Crypt, A Prototype Stem Cell Compartment , 2013, Cell.
[106] R. Nussbaum,et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. , 2010, Human molecular genetics.
[107] D. Murphy,et al. Primary Structure of the Human Platelet Serotonin Uptake Site: Identity with the Brain Serotonin Transporter , 1993, Journal of neurochemistry.
[108] A Chakravarti,et al. Hirschsprung disease, associated syndromes and genetics: a review , 2001, Journal of Medical Genetics.
[109] V. Smith,et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism , 2014, Archives of Disease in Childhood: Education & Practice Edition.
[110] Alan H Feiveson,et al. Varicella-zoster virus in the saliva of patients with herpes zoster. , 2008, The Journal of infectious diseases.
[111] R. Heuckeroth. Hirschsprung's disease, Down syndrome, and missing heritability: too much collagen slows migration. , 2015, The Journal of clinical investigation.
[112] S. Chandra,et al. Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis , 2014, The Journal of Neuroscience.
[113] D. Selkoe,et al. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.
[114] Bradley J. Ferguson,et al. Brief Report: Whole Blood Serotonin Levels and Gastrointestinal Symptoms in Autism Spectrum Disorder , 2016, Journal of autism and developmental disorders.
[115] M. Helwig,et al. Caudo-rostral brain spreading of α-synuclein through vagal connections , 2013, EMBO molecular medicine.
[116] M. Aschner,et al. Advanced Glycation End-Products and Their Receptors: Related Pathologies, Recent Therapeutic Strategies, and a Potential Model for Future Neurodegeneration Studies. , 2016, Chemical research in toxicology.
[117] S. Chandra,et al. Monomeric Synucleins Generate Membrane Curvature* , 2012, The Journal of Biological Chemistry.
[118] M. Gershon,et al. Use of Saliva to Identify Varicella Zoster Virus Infection of the Gut. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[119] H. Reichmann,et al. Does vagotomy reduce the risk of Parkinson's disease? , 2015, Annals of neurology.
[120] M. Chesselet,et al. Mice overexpressing wild‐type human alpha‐synuclein display alterations in colonic myenteric ganglia and defecation , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[121] Carmela Bravaccio,et al. Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives , 2010, Journal of pediatric gastroenterology and nutrition.
[122] Thomas G. Schulze,et al. Defining the Phenotype in Human Genetic Studies: Forward Genetics and Reverse Phenotyping , 2005, Human Heredity.
[123] S. Prusiner,et al. Prion Uptake in the Gut: Identification of the First Uptake and Replication Sites , 2011, PLoS pathogens.
[124] L. Cote,et al. Parkinson's disease and megacolon , 1987, Neurology.
[125] 李春岩. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice , 2012 .
[126] Bradley P. Coe,et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.
[127] Crystal Davis,et al. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS , 2014, Brain Research.
[128] K. Jellinger,et al. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease , 2008, Neuropathology and applied neurobiology.
[129] M. Gershon. Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. , 2012, Transactions of the American Clinical and Climatological Association.
[130] Marta García-Fiñana,et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[131] S. Qualman,et al. Esophageal Lewy bodies associated with ganglion cell loss in achalasia: Similarity to Parkinson's disease , 1984 .
[132] K. Kawai,et al. Annual incidence rates of herpes zoster among an immunocompetent population in the United States , 2015, BMC Infectious Diseases.
[133] E. Masliah,et al. Alzheimer's disease: recent advances and future perspectives. , 2012, Journal of Alzheimer's disease : JAD.
[134] J. Homberg,et al. Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[135] J. Morrissey,et al. The Absence of Tryptophan Hydroxylase Activity in Blood Platelets , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[136] M. Gershon. Developmental determinants of the independence and complexity of the enteric nervous system , 2010, Trends in Neurosciences.
[137] Jane A Foster,et al. In utero exposure to valproic acid and autism--a current review of clinical and animal studies. , 2013, Neurotoxicology and teratology.
[138] A. Gitler,et al. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia , 2016, Journal of neurochemistry.
[139] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[140] Reinhard Schliebs,et al. Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling , 2005, Neurochemical Research.
[141] Jia-Yi Li,et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats , 2014, Acta Neuropathologica.
[142] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[143] S. Bischoff,et al. Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[144] S. Srinivasan,et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease , 2007, Experimental Neurology.
[145] Hitoshi Takahashi,et al. Tyrosine hydroxylase-immunoreactive intrinsic neurons in the Auerbach's and Meissner's plexuses of humans , 1989, Neuroscience Letters.
[146] M. Chesselet,et al. Abnormal colonic motility in mice overexpressing human wild-type &agr;-synuclein , 2008, Neuroreport.
[147] J. Mallet,et al. Serotonin has a key role in pathogenesis of experimental colitis. , 2009, Gastroenterology.
[148] S. Karpen,et al. Gastrointestinal Symptoms in Autism Spectrum Disorder: A Meta-analysis , 2014, Pediatrics.
[149] P. Patterson,et al. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism , 2012, Brain, Behavior, and Immunity.
[150] H. Reichmann,et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice , 2012, Scientific Reports.
[151] D. Murphy,et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[152] A. Kraneveld,et al. Intestinal inflammation in a murine model of autism spectrum disorders , 2014, Brain, Behavior, and Immunity.
[153] J. Petrosino,et al. Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.